Baker Bros. Advisors as of June 30, 2013
Portfolio Holdings for Baker Bros. Advisors
Baker Bros. Advisors holds 75 positions in its portfolio as reported in the June 2013 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Pharmacyclics | 16.9 | $856M | 11M | 79.47 | |
Seattle Genetics | 12.0 | $608M | 19M | 31.46 | |
Genomic Health | 8.6 | $433M | 14M | 31.71 | |
Incyte Genomics Notes 4.75% 10/1/2015 conv bonds | 8.0 | $402M | 158M | 2.55 | |
Synageva Biopharma | 7.7 | $387M | 9.2M | 41.98 | |
ACADIA Pharmaceuticals (ACAD) | 7.2 | $362M | 20M | 18.15 | |
Salix Pharmaceuticals Inc note 2.750% 5/1 | 6.6 | $334M | 219M | 1.52 | |
Incyte Corporation (INCY) | 6.4 | $326M | 15M | 22.00 | |
ViroPharma Incorporated | 4.8 | $244M | 8.5M | 28.65 | |
Auxilium Pharmaceuticals note | 1.7 | $88M | 92M | 0.96 | |
XOMA CORP Common equity shares | 1.5 | $74M | 20M | 3.63 | |
Gilead Sciences (GILD) | 1.3 | $64M | 1.2M | 51.27 | |
Biomarin Pharmaceutical Inc note 1.875% 4/2 | 1.2 | $63M | 23M | 2.76 | |
Aegerion Pharmaceuticals | 1.2 | $59M | 924k | 63.34 | |
Halozyme Therapeutics (HALO) | 1.0 | $52M | 6.6M | 7.95 | |
Repros Therapeutics | 1.0 | $51M | 2.8M | 18.45 | |
Medivation Inc note 2.625% 4/0 | 1.0 | $50M | 40M | 1.27 | |
Gilead Sciences conv | 1.0 | $49M | 22M | 2.26 | |
Itmn 2 1/2 12/15/17 | 0.9 | $44M | 41M | 1.07 | |
BioMarin Pharmaceutical (BMRN) | 0.9 | $44M | 783k | 55.74 | |
Cerus Corporation (CERS) | 0.7 | $37M | 8.5M | 4.42 | |
Clovis Oncology | 0.7 | $35M | 525k | 66.98 | |
Vanda Pharmaceuticals (VNDA) | 0.6 | $32M | 4.0M | 8.08 | |
Ariad Pharmaceuticals | 0.5 | $25M | 1.5M | 17.49 | |
D Stemline Therapeutics | 0.4 | $22M | 900k | 23.84 | |
Intercept Pharmaceuticals In | 0.4 | $21M | 463k | 44.84 | |
Medivation | 0.4 | $20M | 398k | 49.20 | |
Progenics Pharmaceuticals | 0.4 | $19M | 4.2M | 4.46 | |
Derma Sciences | 0.4 | $18M | 1.4M | 13.35 | |
Intermune cv 5.0% | 0.3 | $18M | 17M | 1.05 | |
Infinity Pharmaceuticals (INFIQ) | 0.3 | $17M | 1.0M | 16.19 | |
AVANIR Pharmaceuticals | 0.3 | $17M | 3.6M | 4.60 | |
Questcor Pharmaceuticals | 0.3 | $14M | 316k | 45.44 | |
Chelsea Therapeutics International | 0.2 | $11M | 4.8M | 2.30 | |
Synergy Pharmaceuticals | 0.2 | $11M | 2.6M | 4.32 | |
Insmed (INSM) | 0.2 | $9.5M | 796k | 11.96 | |
Portola Pharmaceuticals | 0.2 | $9.8M | 400k | 24.57 | |
Ironwood Pharmaceuticals (IRWD) | 0.2 | $9.2M | 922k | 9.93 | |
BioCryst Pharmaceuticals (BCRX) | 0.2 | $8.6M | 5.6M | 1.55 | |
Threshold Pharma | 0.2 | $8.4M | 1.6M | 5.26 | |
Synta Pharmaceuticals | 0.1 | $7.0M | 1.4M | 4.99 | |
Array BioPharma | 0.1 | $6.8M | 1.5M | 4.54 | |
ISIS Pharmaceuticals | 0.1 | $6.6M | 247k | 26.87 | |
Qlt | 0.1 | $6.7M | 1.5M | 4.39 | |
XenoPort | 0.1 | $5.1M | 1.0M | 4.95 | |
Anacor Pharmaceuticals | 0.1 | $4.9M | 877k | 5.59 | |
Chemocentryx | 0.1 | $5.3M | 375k | 14.14 | |
Ambit Bioscience | 0.1 | $5.2M | 748k | 7.00 | |
Prothena (PRTA) | 0.1 | $4.8M | 370k | 12.91 | |
Kythera Biopharmaceuticals I | 0.1 | $4.5M | 165k | 27.05 | |
BioDelivery Sciences International | 0.1 | $3.7M | 901k | 4.06 | |
Achillion Pharmaceuticals | 0.1 | $3.7M | 455k | 8.18 | |
Zogenix | 0.1 | $3.4M | 2.0M | 1.71 | |
Puma Biotechnology (PBYI) | 0.1 | $3.7M | 83k | 44.36 | |
Mei Pharma | 0.1 | $3.7M | 516k | 7.13 | |
Salix Pharmaceuticals | 0.1 | $3.0M | 46k | 66.16 | |
Idera Pharmaceuticals | 0.1 | $3.0M | 4.5M | 0.66 | |
INC Ventrus Biosciences | 0.1 | $2.9M | 1.2M | 2.40 | |
Ligand Pharmaceuticals | 0.1 | $2.7M | 73k | 37.40 | |
Discovery Laboratories | 0.1 | $2.3M | 1.5M | 1.52 | |
ArQule | 0.0 | $2.0M | 880k | 2.32 | |
Cytrx | 0.0 | $2.0M | 1.0M | 2.00 | |
Enanta Pharmaceuticals (ENTA) | 0.0 | $2.2M | 125k | 17.71 | |
Receptos | 0.0 | $2.0M | 100k | 19.89 | |
Geron Corporation (GERN) | 0.0 | $1.5M | 1.0M | 1.50 | |
OraSure Technologies (OSUR) | 0.0 | $945k | 244k | 3.88 | |
Amicus Therapeutics (FOLD) | 0.0 | $1.2M | 515k | 2.33 | |
Biodel | 0.0 | $961k | 230k | 4.18 | |
Tesaro | 0.0 | $1.0M | 31k | 32.74 | |
Lpath | 0.0 | $880k | 200k | 4.40 | |
ZIOPHARM Oncology | 0.0 | $536k | 254k | 2.11 | |
Epizyme | 0.0 | $563k | 20k | 28.15 | |
Cubist Pharmaceuticals | 0.0 | $241k | 5.0k | 48.20 | |
Cyclacel Pharmaceuticals Inc pfd conv ex 6% (CYCCP) | 0.0 | $151k | 21k | 7.20 | |
Aradigm Corporation (ARDM) | 0.0 | $16k | 100k | 0.16 |